XGN - Exagen, Inc

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Exagen GAAP EPS of -$0.83 misses by $0.07, revenue of $12.84M beats by $4.14M
• Exagen stock climbs 47% on raised guidance, stronger-than-expected results
• Exagen GAAP EPS, revenue beats, FY22 guidance raised
• Exagen appoints John Aballi as CEO
• Exagen GAAP EPS of -$0.78 misses by $0.21, revenue of $8.96M misses by $3.07M
• Exagen expands coverage for its AVISE tests with MediNcrease provider network
• Exagen GAAP EPS of -$0.60 beats by $0.01, revenue of $10.4M beats by $0.4M
• Exagen expands in-network access for AVISE testing
• Exagen receives DoJ subpoena related to alleged federal healthcare regulations violations
• Exagen GAAP EPS of -$0.42 beats by $0.04, revenue of $12.69M beats by $0.97M
• Exagen EPS beats by $0.02, beats on revenue
• Exagen announces amendment to loan and security agreement
• Exagen surges as Q2 financials exceed expectations indicating sequential growth
• Exagen EPS beats by $0.05, beats on revenue
• Exagen highlights promising data from AVISE lupus test study
• Exagen EPS misses by $0.03, beats on revenue
• Exagen raises $60M via equity offering
• Exagen announces underwritten public offering
• Exagen EPS beats by $0.11, beats on revenue
• Exagen teams up with Tufts Medical Center for its AVISE tests